molnupiravir Archives - Express Pharma

Britain widens access to Pfizer’s COVID anti-viral drug through trial

Pfizer to provide 10 million courses of COVID-19 pill to developing countries: Global Fund

WHO updates its treatment guidelines to include molnupiravir

Movfor phase-III trials show positive results: Hetero

Five-day course of Molnupiravir effective and safe for non-pregnant and unvaccinated COVID-19 adult patients: Study

China approves use of Pfizer’s COVID drug Paxlovid

EU drug regulator OKs Pfizer COVID pill for high-risk patients

SMS Pharmaceuticals receives non-exclusive licence to manufacture and supply Molnupiravir through MPP

Biophore receives sub-licence from MPP to manufacture and market Molnupiravir

Fermenta Biotech licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharma